Form 4: XOMA Royalty Insider Reports Stock Transaction
Insider Transaction (Form 4)
Bvf Partners L P/Il and 9 others reported changes in beneficial ownership of XOMA Royalty Corp common stock on July 14, 2026.
Summary
- Tender of shares: disposed of 3,635,758 Common Stock, $0.0075 par value per share on July 14, 2026 (Direct).
- Tender of shares: disposed of 2,773,545 Common Stock, $0.0075 par value per share on July 14, 2026 (Direct).
- Tender of shares: disposed of 412,000 Common Stock, $0.0075 par value per share on July 14, 2026 (Direct).
- Tender of shares: disposed of 772,000 Common Stock, $0.0075 par value per share on July 14, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Bvf Partners L P/Il — 10% owner
Biotechnology Value Fund L P — 10% owner
Bvf I Gp Llc — 10% owner
Biotechnology Value Fund Ii Lp — 10% owner
Bvf Ii Gp Llc — 10% owner
Biotechnology Value Trading Fund OS LP — Other (See Explanation of Responses)
BVF Partners OS Ltd. — Other (See Explanation of Responses)
Bvf Gp Holdings Llc — 10% owner
Bvf Inc/Il — 10% owner
Mark N Lampert — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Tender of shares | Common Stock, $0.0075 par value per share | 3,635,758 | — | — | 0 |
| 2026-07-14 | Tender of shares | Common Stock, $0.0075 par value per share | 2,773,545 | — | — | 0 |
| 2026-07-14 | Tender of shares | Common Stock, $0.0075 par value per share | 412,000 | — | — | 0 |
| 2026-07-14 | Tender of shares | Common Stock, $0.0075 par value per share | 772,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Tender of shares (3,635,758 shares) |
| 2026-07-14 | Tender of shares (2,773,545 shares) |
| 2026-07-14 | Tender of shares (412,000 shares) |
| 2026-07-14 | Tender of shares (772,000 shares) |
Keywords
insider transaction, Form 4, XOMA, XOMA Royalty Corp, neutral, Bvf Partners L P/Il, Biotechnology Value Fund L P, Bvf I Gp Llc, Biotechnology Value Fund Ii Lp, Bvf Ii Gp Llc, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., Bvf Gp Holdings Llc, Bvf Inc/Il, Mark N Lampert
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.